The August issue of the Bloomsbury IP/IT Law Briefing is now available for subscribers.
This month’s IP/IT Law Briefing summarises recent judgments from the England and Wales courts and the Unified Patent Court (UPC).
In the Patents Court, His Honour Judge Hacon has found a patent for a voltage regulator to be invalid for lack of inventive step in R2 Semiconductor, Inc v Intel Corporation (UK) Ltd & Anor [2024] EWHC 1974 (Pat).
Mr Justice Meade found that a second medical use patent for the use of the antibody ustekinumab to treat ulcerative colitis (UC) was obvious over a set of slides that presented the results of a clinical trial in Samsung Bioepis UK Ltd v Janssen Biotech Inc [2024] EWHC 1984 (Pat).
In Cloud Cycle Ltd v Verifi LLC & Anor [2024] EWHC 2001 (Ch), Recorder Douglas Campbell KC found no infringement under the doctrine of equivalents. The patent related to a method for calculating and reporting a property of concrete called slump in a concrete delivery truck.
The employee compensation litigation between Dr David Parsons and his former employee, Convatec, has moved one step closer to resolution, after Deputy Judge Pat Treacy ruled on how to identify the invention (Parsons v Convatec Ltd [2024] EWHC 2111 (Pat)).
His Honour Judge Cawson KC declined to grant an application for summary judgment in a case concerning the ownership of IP rights relating to software in point-of-sale cash registers (Clearcourse Partnership Acquireco Ltd & Anor v Jethwa & Ors [2024] EWHC 1964 (Ch)).
At the UPC, the Court of Appeal of the Unified Patent Court (UPC) ordered that a defendant company in China or Taiwan cannot, as a starting point, be served a statement of claim via a company within the same group based in a UPC member state (Daedalus Prime LLC v Xiaomi Communications Co., Ltd. et al (UPC_CoA_183/2024)).
In Sibio Technology Limited, Umedwings Netherlands B.V. v Abbott Diabetes Care Inc. (UPC_CoA_388/2024), the Court of Appeal ruled that only countries that have signed and ratified the UPC Agreement are contracting member states. An injunction extending to Ireland was therefore suspended.
In a case brought by Amycel against an unknown defendant, the local division of The Hague ruled that ‘mushroom strain is not considered to be excluded from patentability (Article 53(b) EPC)’ (Amycel LLC v Anonymous (UPC_CFI_195/2024)).
Finally, in Mathys & Squire LLP (UPC_CFI_75/2023), the Munich local division ruled that once UPC proceedings have come to an end (for example after a settlement), the balance of interests will normally favour granting access to written pleadings and evidence.